Found: 148
Select item for more details and to access through your institution.
ADAMTS5 Is a Critical Regulator of Virus-Specific T Cell Immunity.
- Published in:
- PLoS Biology, 2016, v. 14, n. 11, p. 1, doi. 10.1371/journal.pbio.1002580
- By:
- Publication type:
- Article
Zinc affects miR-548n, SMAD4, SMAD5 expression in HepG2 hepatocyte and HEp-2 lung cell lines.
- Published in:
- BioMetals, 2015, v. 28, n. 6, p. 959, doi. 10.1007/s10534-015-9880-6
- By:
- Publication type:
- Article
Advancing SERS Diagnostics in COVID‐19 with Rapid, Accurate, and Label‐Free Viral Load Monitoring in Clinical Specimens via SFNet Enhancement.
- Published in:
- Advanced Materials Interfaces, 2024, v. 11, n. 18, p. 1, doi. 10.1002/admi.202400013
- By:
- Publication type:
- Article
Reversible disruption of XPO1-mediated nuclear export inhibits respiratory syncytial virus (RSV) replication.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-98767-2
- By:
- Publication type:
- Article
Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-97658-w
- By:
- Publication type:
- Article
siRNA Genome Screening Approaches to Therapeutic Drug Repositioning.
- Published in:
- Pharmaceuticals (14248247), 2013, v. 6, n. 2, p. 124, doi. 10.3390/ph6020124
- By:
- Publication type:
- Article
Correction: ADAMTS5 Is a Critical Regulator of Virus-Specific T Cell Immunity.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Microparticle RSV Vaccines Presenting the G Protein CX3C Chemokine Motif in the Context of TLR Signaling Induce Protective Th1 Immune Responses and Prevent Pulmonary Eosinophilia Post-Challenge.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2078, doi. 10.3390/vaccines10122078
- By:
- Publication type:
- Article
Influenza B Virus (IBV) Immune-Mediated Disease in C57BL/6 Mice.
- Published in:
- Vaccines, 2022, v. 10, n. 9, p. 1440, doi. 10.3390/vaccines10091440
- By:
- Publication type:
- Article
Advances in Vaccine Development.
- Published in:
- Vaccines, 2021, v. 9, n. 9, p. 1036, doi. 10.3390/vaccines9091036
- By:
- Publication type:
- Article
ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 527, doi. 10.3390/vaccines9050527
- By:
- Publication type:
- Article
Accidental Interruption of the Cold Chain for the Preservation of the Moderna COVID-19 Vaccine.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 484, doi. 10.3390/vaccines9050484
- By:
- Publication type:
- Article
Prevalence and Potential Determinants of COVID-19 Vaccine Hesitancy and Resistance in Qatar: Results from a Nationally Representative Survey of Qatari Nationals and Migrants between December 2020 and January 2021.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 471, doi. 10.3390/vaccines9050471
- By:
- Publication type:
- Article
Sensitivity to COVID-19 Vaccine Effectiveness and Safety in Shanghai, China.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 472, doi. 10.3390/vaccines9050472
- By:
- Publication type:
- Article
Chimeric RHDV Virus-Like Particles Displaying Foot-and-Mouth Disease Virus Epitopes Elicit Neutralizing Antibodies and Confer Partial Protection in Pigs.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 470, doi. 10.3390/vaccines9050470
- By:
- Publication type:
- Article
Post-Marketing Active Surveillance of Adverse Reactions Following Influenza Cell-Based Quadrivalent Vaccine: An Italian Prospective Observational Study.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 456, doi. 10.3390/vaccines9050456
- By:
- Publication type:
- Article
Comparative Evaluation of Growth Performance between Bivalent and Trivalent Vaccines Containing Porcine Circovirus Type 2 (PCV2) and Mycoplasma hyopneumoniae in a Herd with Subclinical PCV2d Infection and Enzootic Pneumonia.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 450, doi. 10.3390/vaccines9050450
- By:
- Publication type:
- Article
An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 433, doi. 10.3390/vaccines9050433
- By:
- Publication type:
- Article
Conformational and Immunogenicity Studies of the Shigella flexneri Serogroup 6 O-Antigen: The Effect of O-Acetylation.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 432, doi. 10.3390/vaccines9050432
- By:
- Publication type:
- Article
Balanced Cellular and Humoral Immune Responses Targeting Multiple Antigens in Adults Receiving a Quadrivalent Inactivated Influenza Vaccine.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 426, doi. 10.3390/vaccines9050426
- By:
- Publication type:
- Article
Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 393, doi. 10.3390/vaccines9040393
- By:
- Publication type:
- Article
Advances in Toxoplasma gondii Vaccines: Current Strategies and Challenges for Vaccine Development.
- Published in:
- Vaccines, 2021, v. 9, n. 5, p. 413, doi. 10.3390/vaccines9050413
- By:
- Publication type:
- Article
Field Evaluation of Commercial Vaccines against Infectious Bovine Rhinotracheitis (Ibr) Virus Using Different Immunization Protocols.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 408, doi. 10.3390/vaccines9040408
- By:
- Publication type:
- Article
AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 403, doi. 10.3390/vaccines9040403
- By:
- Publication type:
- Article
The Effect of Vaccination with Neospora caninum Live-Frozen Tachyzoites on Abortion Rates of Naturally Infected Pregnant Cows.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 401, doi. 10.3390/vaccines9040401
- By:
- Publication type:
- Article
COVID-19 Vaccination Scenarios: A Cost-Effectiveness Analysis for Turkey.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 399, doi. 10.3390/vaccines9040399
- By:
- Publication type:
- Article
COVID-19 and Pregnancy: Vertical Transmission and Inflammation Impact on Newborns.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 391, doi. 10.3390/vaccines9040391
- By:
- Publication type:
- Article
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 395, doi. 10.3390/vaccines9040395
- By:
- Publication type:
- Article
Letermovir Primary Prophylaxis in High-Risk Hematopoietic Cell Transplant Recipients: A Matched Cohort Study.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 372, doi. 10.3390/vaccines9040372
- By:
- Publication type:
- Article
Preclinical Marmoset Model for Targeting Chronic Inflammation as a Strategy to Prevent Alzheimer's Disease.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 388, doi. 10.3390/vaccines9040388
- By:
- Publication type:
- Article
Modeling of Vaccination and Contact Tracing as Tools to Control the COVID-19 Outbreak in Spain.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 386, doi. 10.3390/vaccines9040386
- By:
- Publication type:
- Article
Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4 + T Cells Associated with Poor Disease-Specific Survival.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 334, doi. 10.3390/vaccines9040334
- By:
- Publication type:
- Article
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 359, doi. 10.3390/vaccines9040359
- By:
- Publication type:
- Article
The C-Terminal Domain of Nef mut Is Dispensable for the CD8 + T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 373, doi. 10.3390/vaccines9040373
- By:
- Publication type:
- Article
Construction of Porcine Epidemic Diarrhea Virus-Like Particles and Its Immunogenicity in Mice.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 370, doi. 10.3390/vaccines9040370
- By:
- Publication type:
- Article
Impact of Media Coverage on Influenza Vaccine Coverage in Elderly Individuals from 2020 to 2021 in the Republic of Korea.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 367, doi. 10.3390/vaccines9040367
- By:
- Publication type:
- Article
Influenza Vaccination and Health Outcomes in COVID-19 Patients: A Retrospective Cohort Study.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 358, doi. 10.3390/vaccines9040358
- By:
- Publication type:
- Article
Concomitant Swine Influenza A Virus Infection Alters PRRSV1 MLV Viremia in Piglets but Does Not Interfere with Vaccine Protection in Experimental Conditions.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 356, doi. 10.3390/vaccines9040356
- By:
- Publication type:
- Article
The COVID-19 Vaccines: Recent Development, Challenges and Prospects.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 349, doi. 10.3390/vaccines9040349
- By:
- Publication type:
- Article
COVID-19's Impact on Willingness to Be Vaccinated against Influenza and COVID-19 during the 2020/2021 Season: Results from an Online Survey of Canadian Adults 50 Years and Older.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 346, doi. 10.3390/vaccines9040346
- By:
- Publication type:
- Article
Factors Influencing the Efficacy of COVID-19 Vaccines: A Quantitative Synthesis of Phase III Trials.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 341, doi. 10.3390/vaccines9040341
- By:
- Publication type:
- Article
Epidemiological and Clinical Observations of Gonococcal Infections in Women and Prevention Strategies.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 327, doi. 10.3390/vaccines9040327
- By:
- Publication type:
- Article
The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 326, doi. 10.3390/vaccines9040326
- By:
- Publication type:
- Article
Systematic Booster after Rabies Pre-Exposure Prophylaxis to Alleviate Rabies Antibody Monitoring in Individuals at Risk of Occupational Exposure.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 309, doi. 10.3390/vaccines9040309
- By:
- Publication type:
- Article
A Vaccine Strain of the A/ASIA/Sea-97 Lineage of Foot-and-Mouth Disease Virus with a Single Amino Acid Substitution in the P1 Region That Is Adapted to Suspension Culture Provides High Immunogenicity.
- Published in:
- Vaccines, 2021, v. 9, n. 4, p. 308, doi. 10.3390/vaccines9040308
- By:
- Publication type:
- Article
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 291, doi. 10.3390/vaccines9030291
- By:
- Publication type:
- Article
The Impact of a Single Educational Lecture on the Vaccine Confidence among Pregnant Women and Young Mothers.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 290, doi. 10.3390/vaccines9030290
- By:
- Publication type:
- Article
A Call for a Reform of the Influenza Immunization Program in Mexico: Epidemiologic and Economic Evidence for Decision Making.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 286, doi. 10.3390/vaccines9030286
- By:
- Publication type:
- Article
Immunization with Epstein–Barr Virus Core Fusion Machinery Envelope Proteins Elicit High Titers of Neutralizing Activities and Protect Humanized Mice from Lethal Dose EBV Challenge.
- Published in:
- Vaccines, 2021, v. 9, n. 3, p. 285, doi. 10.3390/vaccines9030285
- By:
- Publication type:
- Article